0002056611-25-000001.txt : 20250213 0002056611-25-000001.hdr.sgml : 20250213 20250213163639 ACCESSION NUMBER: 0002056611-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250213 DATE AS OF CHANGE: 20250213 EFFECTIVENESS DATE: 20250213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Latigo Biotherapeutics, Inc. CENTRAL INDEX KEY: 0002056611 ORGANIZATION NAME: IRS NUMBER: 832625838 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-538236 FILM NUMBER: 25620935 BUSINESS ADDRESS: STREET 1: 1300 RANCHO CONEJO BLVD. SUITE 305 CITY: THOUSAND OAKS STATE: CA ZIP: 91320 BUSINESS PHONE: 805-716-2927 MAIL ADDRESS: STREET 1: 1300 RANCHO CONEJO BLVD. SUITE 305 CITY: THOUSAND OAKS STATE: CA ZIP: 91320 D 1 primary_doc.xml X0708 D LIVE 0002056611 Latigo Biotherapeutics, Inc. 1300 RANCHO CONEJO BLVD. SUITE 305 THOUSAND OAKS CA CALIFORNIA 91320 805-716-2927 DELAWARE Desmond, Inc. None Corporation true Nima Farzan c/o Latigo Biotherapeutics, Inc. 1300 Rancho Conejo Blvd. Suite 305 Thousand Oaks CA CALIFORNIA 91320 Executive Officer Director Kevin Raidy c/o Latigo Biotherapeutics, Inc. 1300 Rancho Conejo Blvd. Suite 305 Thousand Oaks CA CALIFORNIA 91320 Director Jim Tananbaum c/o Latigo Biotherapeutics, Inc. 1300 Rancho Conejo Blvd. Suite 305 Thousand Oaks CA CALIFORNIA 91320 Director Beth Seidenberg c/o Latigo Biotherapeutics, Inc. 1300 Rancho Conejo Blvd. Suite 305 Thousand Oaks CA CALIFORNIA 91320 Director Deborah Palestrant c/o Latigo Biotherapeutics, Inc. 1300 Rancho Conejo Blvd. Suite 305 Thousand Oaks CA CALIFORNIA 91320 Director Tim Walbert c/o Latigo Biotherapeutics, Inc. 1300 Rancho Conejo Blvd. Suite 305 Thousand Oaks CA CALIFORNIA 91320 Director Nancy Stagliano c/o Latigo Biotherapeutics, Inc. 1300 Rancho Conejo Blvd. Suite 305 Thousand Oaks CA CALIFORNIA 91320 Director Tim Lugo c/o Latigo Biotherapeutics, Inc. 1300 Rancho Conejo Blvd. Suite 305 Thousand Oaks CA CALIFORNIA 91320 Executive Officer Biotechnology Decline to Disclose 06b false 2025-01-28 false true false 0 149999990 49999995 99999995 false 7 0 0 0 false Latigo Biotherapeutics, Inc. /s/ Tim Lugo Tim Lugo Chief Financial Officer 2025-02-13